In the last trading session, 25.59 million shares of the Hims & Hers Health Inc (NYSE:HIMS) were traded, and its beta was 1.37. Most recently the company’s share price was $40.68, and it changed around -$4.41 or -9.78% from the last close, which brings the market valuation of the company to $9.04B. HIMS currently trades at a discount to its 52-week high of $72.98, offering almost -79.4% off that amount. The share price’s 52-week low was $11.20, which indicates that the current value has risen by an impressive 72.47% since then.
Hims & Hers Health Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.53. If we narrow it down even further, the data shows that 1 out of 15 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 7 recommended HIMS as a Hold, whereas 4 deemed it a Buy, and 1 rated it as Underweight. Hims & Hers Health Inc is expected to report earnings per share of 0.21 for the current quarter.
Hims & Hers Health Inc (NYSE:HIMS) trade information
Instantly HIMS has showed a red trend with a performance of -9.78% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 46.35 on recent trading dayincreased the stock’s daily price by 12.23%. The company’s shares are currently up 68.24% year-to-date, but still down -20.72% over the last five days. On the other hand, Hims & Hers Health Inc (NYSE:HIMS) is 19.79% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $25.5, which translates to bulls needing to decrease their stock price by -59.53% from its current value. Analyst projections state that HIMS is forecast to be at a low of $21 and a high of $68.
Hims & Hers Health Inc (HIMS) estimates and forecasts
The year-over-year growth rate is expected to be 57.01%, up from the previous year.
Consensus estimates provided by 10 financial analysts predict the company will bring in an average of 534.97M in revenue for the current quarter. 10 analysts expect Hims & Hers Health Inc to make 564.16M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 278.17M and 315.65M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 92.32%. Forecasts for the next quarter put sales growth at 78.73%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 17.22%. Hims & Hers Health Inc earnings are expected to increase by 10.53% in 2025, but the outlook is positive 30.61% per year for the next five years.
HIMS Dividends
Hims & Hers Health Inc’s next quarterly earnings report is expected to be released in April.
BLACKROCK INC., with 6.8278% or 14.57 million shares worth $294.25 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
iShares Core S&P Smallcap ETF and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 12.32 shares worth $501.31 million, making up 5.76% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 5.31 shares worth around $216.06 million, which represents about 2.48% of the total shares outstanding.
